Loading clinical trials...
Loading clinical trials...
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia
Conditions
Interventions
Rituximab+mVPDL
Locations
19
South Korea
Chonnam National University Hwasun Hospital
Hwasun, Chollanamdo, South Korea
Hematologic Oncology Clinic, National Cancer Center
Ilsan, Kongki, South Korea
Division of Hematology-Oncology, Dong-A University College of Medicine
Busan, South Korea
Dong-A University College of Medicine
Busan, South Korea
Inje University Busan Paik Hospital
Busan, South Korea
Inje University Haeundae-Paik Hospital
Busan, South Korea
Start Date
November 1, 2011
Primary Completion Date
January 1, 2018
Completion Date
January 1, 2019
Last Updated
July 24, 2018
NCT07499128
NCT05026229
NCT03545659
Lead Sponsor
Asan Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions